ArticleOphthalmology science

Phase I Study of Intravitreal Injection of Autologous CD34+ Stem Cells from Bone Marrow in Eyes with Vision Loss from Retinitis Pigmentosa.

Susanna S Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.